"Letter by Kounis et al Regarding Article, “Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine”." Circulation: Heart Failure, 15(10), pp. e009826–

Footnotes

For Disclosures, see page 1004.

1. Sung K, McCain J, King KR, Hong K, Aisagbonhi O, Adler ED, Urey MA. Biopsy-proven giant cell myocarditis following the COVID-19 vaccine.Circ Heart Fail. 2022; 15:e009321. doi: 10.1161/CIRCHEARTFAILURE.121.009321LinkGoogle Scholar2. Kounis NG, Koniari I, de Gregorio C, Assimakopoulos SF, Velissaris D, Hung MY, Mplani V, Saba L, Brinia A, Kouni SN, et al.. COVID-19 disease, women’s predominant non-heparin vaccine-induced thrombotic thrombocytopenia and kounis syndrome: a passepartout cytokine storm interplay.Biomedicines. 2021; 9:959. doi: 10.3390/biomedicines9080959CrossrefMedlineGoogle Scholar3. Kounis NG, Zavras GM, Soufras GD, Kitrou MP. Hypersensitivity myocarditis.Ann Allergy. 1989; 62:71–74.MedlineGoogle Scholar4. Lee JH, Kim AR, Lee SE, Song WJ, Kwon HS, Kim TB, Kim JJ, Cho YS. Eosinophilic myocarditis progresses to giant cell myocarditis requiring heart transplantation: a case report.Allergy Asthma Immunol Res. 2021; 13:353–355. doi: 10.4168/aair.2021.13.2.353CrossrefMedlineGoogle Scholar5. Mortz CG, Kjaer HF, Rasmussen TH, Rasmussen HM, Garvey LH, Bindslev-Jensen C. Allergy to polyethylene glycol and polysorbates in a patient cohort: diagnostic work-up and decision points for vaccination during the COVID-19 pandemic.Clin Transl Allergy. 2022; 12:e12111. doi: 10.1002/clt2.12111CrossrefMedlineGoogle Scholar